tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT

Compare Immunovant (IMVT) vs. Competitors

Compare
922 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$26.27
$5.29B
-9.29
10.38%
7 Buy
2 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$81.99
$5.13B
129.44
124.38%
11 Buy
1 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$55.99
$5.74B
-12.35
53.48%
12 Buy
0 Hold
0 Sell
Strong Buy
Mirum Pharmaceuticals
$91.05
$4.71B
-105.65
98.67%
10 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$69.54
$5.49B
-19.34
72.60%
21 Buy
1 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$16.76
$1.20B
-5.04
-59.59%
9 Buy
1 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
26.27
2.68
11.36%
PTGX
Protagonist Therapeutics
81.99
43.89
115.20%
CRNX
Crinetics Pharmaceuticals
55.99
17.23
44.45%
MIRM
Mirum Pharmaceuticals
91.05
43.07
89.77%
KYMR
Kymera Therapeutics
69.54
25.84
59.13%
MLTX
MoonLake Immunotherapeutics
16.76
-29.06
-63.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts